Novanta Inc (NOVT) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.
Total Revenue Chart for Novanta Inc
Novanta Inc (NOVT) revenue for FY2025 was USD 980.6M, a 3.3% change from FY2024. Novanta Inc's revenue grew from USD 144.2M in 1998 to USD 980.6M in 2025 (580.0% over 27 years). Earnings per share grew from USD 3.40 in 2000 to USD 2.06 in 2022 (-39.4%). Revenue compound annual growth rate: 5-year CAGR of 10.7%, 10-year CAGR of 10.1%, 20-year CAGR of 6.8%.
Total Revenue (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $5.64B
- Implied Share Price
- $149.10
- Enterprise Value
- $5.21B
- Revenue (TTM)
- $1.03B
- EBITDA
- $180.95M
- Profit Margin
- 6.00%
- Trailing P/E
- 94.37
- Forward P/E
- 8.39
- Price/Book (MRQ)
- 3.38
- Price/Sales (TTM)
- 5.53
- EV/EBITDA
- 27.69
- EV/Revenue
- 4.88
- Dividend Yield
- —
- Book Value
- $42.74
- Free Cash Flow (FY2025)
- $48.43M
- Free Cash Flow Yield
- 0.86%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.